We are proud to announce that the Saudi Food and Drug Authority (SFDA) has officially classified Cebedi® as a food supplement in the Kingdom of Saudi Arabia. This milestone affirms the brand’s positioning as a next-generation wellness solution and accelerates its availability to consumers across the Middle East.
Cebedi®: Ultra-Pure Synthetic CBD with Pharmaceutical-Grade Precision
The Cebedi® brand was born from a simple but ambitious vision: to elevate CBD beyond trend-driven wellness into a scientifically grounded, regulated supplement category. At its core is synthetic CBD, offering unmatched purity, consistency, and safety compared to plant-derived alternatives. Manufactured under GMP-certified conditions, Cebedi® guarantees pharmaceutical-level quality in every capsule, oil, and topical.
Cebedi® now stands among the pioneering global brands recognized as a food supplement, joining a select group of early innovators shaping the cannabinoid regulatory pathway. With approvals in strategic markets such as the UK, Saudi Arabia, UAE, and Jordan, this recognition represents a turning point in how cannabinoids are understood and accepted in mainstream nutrition. Increasingly, regulatory bodies worldwide are acknowledging that synthetic CBD—when developed to pharmaceutical standards—can safely and effectively support consumer wellbeing.
Portfolio & Innovation
Cebedi® Oils and Capsules – formulated for precise dosing and daily balance.
With scientific collaborations, expanding international approvals, and growing consumer trust, Heilmittel Group is demonstrating that cannabinoids, when standardized and responsibly presented, have a rightful place in modern nutrition science.
This SFDA classification marks not only an important regulatory achievement for Cebedi®, but also a milestone for the global CBD industry, paving the way for wider acceptance of safe, science-driven cannabinoid supplements.